Get startedLog in
    Picture of ISR Immune System Regulation Holding AB (publ) logo

    ISR — ISR Immune System Regulation Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: ISR Immune System Regulation Holding Preclinical Study Shows Protection Against SARS-CoV-2

    Picture of ISR Immune System Regulation Holding AB (publ) logoISR Immune System Regulation Holding AB (publ)
    02/06/2022 11:07
    June 2 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * PRECLINICAL STUDY SHOWS THAT ISR-052 PROVIDES LONG TERM
PROTECTION AGAINST SARS-COV-2
    * ISR HAS CONDUCTED AN ANIMAL STUDY THAT SHOWS THAT
IMMUNOLOGICAL
MEMORY REMAINS 6 MONTHS AFTER TWO DOSES OF THE COMPANY'S NASAL
VACCINE CANDIDATE, ISR-52

Source text for Eikon:  ID:nWkr9kRJfP 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ISR Immune System Regulation Holding AB (publ)

    See all news